MTOR and neoplasm with perivascular epithelioid cell differentiation: PEComas are usually considered chemoresistant tumors, but published reports of responses obtained with the mTOR-inhibitors sirolimus and temsirolimus [5-9] provided the rationale for the use of an agent of this class.